BioSig Technologies, Inc. (BSGM)
$0.47-72.19%Close
SELLCRISIS · day 6
Key stats
- Market cap
- $15M
- Beta
- 1.82
- P/E (TTM)
- -5.04
- 1W
- -76.50%
- 1M
- -62.40%
- vs SPY 1W
- -75.52%
- vs SPY 1M
- -64.26%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 6
- VALUE
- 0
- GROWTH
- 35
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-27.5%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-5.04
P/E FWD-
SECTOR PE20.48
INDUSTRY PE22.31
P/B-298.27
P/FCF-
EV/EBITDA-5.19
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.12
ND/EBITDA-
BETA1.82
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on BSGM?
- LOPJLB’s latest quantitative signal on BioSig Technologies, Inc. (BSGM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is BSGM in?
- BioSig Technologies, Inc. (BSGM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does BioSig Technologies, Inc. (BSGM) do?
- BioSig Technologies, Inc., along with its subsidiaries, operates as a medical technology enterprise. Its core innovation is the PURE EP (precise uninterrupted real-time evaluation of electrograms electrophysiology) system. This proprietary signal processing platform, merging specialized hardware and software, tackles well-known difficulties in electrophysiological signal acquisition, empowering…